Pharma Execs Rarely Charged When Their Companies Break the Law
A new study in JAMA Internal Medicine shines a light on the lack of accountability for pharma execs who engage in criminal activities.
United States Aarons Kesselheim C Joseph Ross Daval Elizabeth Holmes Jerry Avorn Program On Regulation
Source: madinamerica.com